Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
measurement at 412 nm absorbance (Fig
Clin Microbiol Rev 32, e00001e00019.CrossRefGoogle ScholarPubMed An addendum has been issued for this article: 29 Cited by Linked content Please note an has been issued for this article.
BioWorld - Sunday, August 2, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home Viking Therapeutics presents GLP-1 and GDIR dual agonists To read the full story, subscribe or sign in
The results of the analysis show the challenges for central key actors and their interactions in intra-national cross-border interactions
At the same time, the equity questions are just as important as the efficacy curves: Who will actually have access to orforglipron once it is approved
2004 Apr;16(2):135-42
US$ 25.14
US$ 22.84
US$ 29.24
US$ 26.07
US$ 26.13
US$ 23.64
